Clinical Program Lead (CPL) - RLT Focus

Major Accountabilities

• Provides strategic medical and scientific leadership and expertise to all line functions on the project team for the development of new oncology agents (e.g., small molecules, biologics, radioligand therapies) that are in preclinical development, typically beginning at the PE/DC
• Creates clinical development strategies for new oncology agents within the PE/DC to TDP timeframe, combining medical knowledge with expertise of colleagues in Clinical Pharmacology, Biostatistics and other disciplines
• Provides an early clinical development strategy that foresees and supports subsequent registration trials; develops the Integrated Development Plan Approval (IDPA) in alignment with CPL Disease Area Leads, Development, Strategy & Growth, and Commercial teams
• Leads Biomedical Research Early Program Teams (BPTs) to enable the start of clinical development and continuing through clinical trials needed to support TDP; may lead multiple global project teams
• Integrates preclinical information (pharmacology, toxicology, and pharmacokinetics) and interprets implications for clinical development, as articulated in the Investigator's Brochure and First-in-Human protocol
• Collaborates with clinical scientists to develop clinical protocols for TCO compounds and develop the instruments needed to implement, interpret and report them (e.g., case report forms, report and analysis plans, clinical study reports)
• Applies medical knowledge to guide the safe, ethical and efficient conduct of the trials; knowledgeable in Good Clinical Practice guidelines and Novartis Standard Operating Procedures
• Liaises with outside experts, investigators, and regulatory authorities in oncology, and represents own projects to those groups and authorities
• Writes and reviews abstracts/manuscripts for presentation/publications at internal/external meetings
• Participates in task forces to support continuous improvement and other management objectives; operational responsibility for quality and compliance
• May provide informal mentorship to less experienced CPLs

Qualifications

Education: MD or DO degree. Board-certification in an oncology specialty and PhD-level science are preferred.

Languages: Fluent English – Oral and written.

Experience/Professional Requirements

• At least 2 years of pharmaceutical/biotech industry experience in oncology clinical trials plus the equivalent duration experience from an academic medical center; if limited or no Pharmaceutical industry experience, then comparable senior academic experience in translational oncology and clinical research
• Experience within RLT preferred
• Recognized as an expert in your field by external medical experts; external candidates have a substantial record of publication and international recognition
• Excellent interpretation of oncology preclinical data (molecular biology, pharmacology, pharmacokinetics, and toxicology)
• Strong knowledge of the application of PK/PD and biostatistics to clinical development and clinical trials
• Proven ability to analyze and interpret efficacy and safety data relating to oncology
• Knowledge of GCP and world-wide regulatory requirements for clinical trials and oncology
• Excellent medical/scientific writing skills
• Successful track record of strategic thinking
• Proven ability to develop and inspire project/line/matrix multidisciplinary teams in a global environment
• Excellent personal ethical integrity and a commitment to improving the outcomes for patients with malignancies
• Excellent written and oral English communication/presentation skills
• Strong office IT skills